Detail akcie Medtronic online

Business Summary: Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Financial Summary: BRIEF: For the nine months ended 26 January 2024, Medtronic PLC revenues increased 5% to $23.78B. Net income applicable to common stockholders increased 17% to $3.02B. Revenues reflect Cardiovascular segment increase of 6% to $8.7B, Neuroscience segment increase of 5% to $6.86B, Rest of World segment increase of 7% to $11.47B, United States segment increase of 3% to $12.22B. Net income benefited from Interest Income increase of 74% to $429M (income).